After two years of civil war, government troops are gaining control over Sudan’s capital. The country’s de facto leader Abdel ...

EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 80th Emerging Growth ...

Bioxytran inks non-disclosure agreement with University of Georgia to evaluate Galectin antagonists for bird flu treatment in chickens: Boston Friday, March 21, 2025, 15:00 Hrs [I ...

3月18日，垦利区董集镇一位八旬老人不慎落水。危急时刻，同村村民王建龙奋不顾身跳入湖中施救。王建龙在众人的帮助下，将老人迅速救起。

BOSTON, MASSACHUSETTS, March 19, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral ...

New water-soluble galectin antagonist being considered in preclinical trials offering hope for rapid containment to H5N1 outbreaksBOSTON, ...

(OTCQB: BIXT) (the“Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, unveiled a potential game-changer in the fight against ...

BOSTON, MASSACHUSETTS, March 12, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral ...

22, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, ...

BiXT is a novel bi-directional Transformer architecture which scales linearly with input size in terms of computational cost and memory consumption, but does not suffer the drop in performance or ...